Formosa Laboratories Valuation
| 4746 Stock | TWD 76.00 0.40 0.53% |
At this time, the firm appears to be overvalued. Formosa Laboratories shows a prevailing Real Value of NT$63.84 per share. The current price of the firm is NT$76.0. Our model computes the value of Formosa Laboratories from reviewing the firm fundamentals such as Profit Margin of (0.03) %, current valuation of 9.7 B, and Shares Outstanding of 120.26 M as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Formosa Laboratories' price fluctuation is very steady at this time. Calculation of the real value of Formosa Laboratories is based on 3 months time horizon. Increasing Formosa Laboratories' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Formosa stock is determined by what a typical buyer is willing to pay for full or partial control of Formosa Laboratories. Since Formosa Laboratories is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Formosa Stock. However, Formosa Laboratories' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 76.0 | Real 63.84 | Hype 76.0 |
The intrinsic value of Formosa Laboratories' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Formosa Laboratories' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Formosa Laboratories helps investors to forecast how Formosa stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Formosa Laboratories more accurately as focusing exclusively on Formosa Laboratories' fundamentals will not take into account other important factors: Formosa Laboratories Total Value Analysis
Formosa Laboratories is presently anticipated to have takeover price of 9.7 B with market capitalization of 8.08 B, debt of 1.91 B, and cash on hands of 756.11 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Formosa Laboratories fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
9.7 B | 8.08 B | 1.91 B | 756.11 M |
Formosa Laboratories Investor Information
About 21.0% of the company shares are owned by insiders or employees . The company has Price-to-Book (P/B) ratio of 1.02. In the past many companies with similar price-to-book ratios have beat the market. Formosa Laboratories recorded a loss per share of 1.85. The entity last dividend was issued on the 27th of July 2022. The firm had 1949:1934 split on the 5th of March 2020. Based on the key indicators related to Formosa Laboratories' liquidity, profitability, solvency, and operating efficiency, Formosa Laboratories is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Formosa Laboratories Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The latest return on assets of Formosa indicates not a very effective usage of assets in December.Formosa Laboratories Ownership Allocation
Formosa Laboratories holds a total of 120.26 Million outstanding shares. Formosa Laboratories retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Formosa Laboratories Profitability Analysis
The company reported the revenue of 3.14 B. Net Income was 1.25 B with profit before overhead, payroll, taxes, and interest of 971.44 M.About Formosa Laboratories Valuation
Our relative valuation model uses a comparative analysis of Formosa Laboratories. We calculate exposure to Formosa Laboratories's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Formosa Laboratories's related companies.Formosa Laboratories, Inc. produces and sells active pharmaceutical ingredients and UV-filters worldwide. The company was founded in 1995 and is based in Taoyuan, Taiwan. FORMOSA LABORATORIES operates under Drug Manufacturers - Specialty Generic classification in Taiwan and is traded on Taiwan Stock Exchange.
8 Steps to conduct Formosa Laboratories' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Formosa Laboratories' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Formosa Laboratories' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Formosa Laboratories' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Formosa Laboratories' revenue streams: Identify Formosa Laboratories' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Formosa Laboratories' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Formosa Laboratories' growth potential: Evaluate Formosa Laboratories' management, business model, and growth potential.
- Determine Formosa Laboratories' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Formosa Laboratories' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Formosa Stock Analysis
When running Formosa Laboratories' price analysis, check to measure Formosa Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Formosa Laboratories is operating at the current time. Most of Formosa Laboratories' value examination focuses on studying past and present price action to predict the probability of Formosa Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Formosa Laboratories' price. Additionally, you may evaluate how the addition of Formosa Laboratories to your portfolios can decrease your overall portfolio volatility.